Related Experiment Video
Updated: Dec 20, 2025

Author Spotlight: Implementation of BIVA for Analyzing Disease Risk Factors in Patients with Low Body Cell Mass
Published on: July 14, 2023
Cachexia in patients with rheumatoid arthritis: a cohort study
Rafaela Ce Santo1,2,3, Jordana Ms Silva4,5,6, Priscila S Lora7
1Hospital de Clínicas de Porto Alegre, Laboratório de Doenças Autoimunes, Porto Alegre, Brazil. rcsanto@hcpa.edu.br.
Rheumatoid cachexia (RC) is common in rheumatoid arthritis (RA) patients, unlike classic cachexia. Disease activity and biologic treatments impact body composition and physical function in RA.
Area of Science:
- Rheumatology
- Body Composition Analysis
- Inflammatory Diseases
Background:
- Rheumatoid arthritis (RA) is an inflammatory condition causing significant body composition alterations.
- Rheumatoid cachexia (RC) is characterized by lean mass loss with preserved or increased fat mass, distinct from classic cachexia.
- Limited data exist on RC prevalence, progression, and associated factors in RA patients.
Purpose of the Study:
- To determine the prevalence of cachexia in RA patients.
- To identify factors associated with cachexia development and progression in RA.
Main Methods:
- A prospective cohort study followed 81 RA patients for 1 year.
- Assessed clinical features, body composition, physical function, and diagnosed RC/classic cachexia using established criteria.
- Statistical analyses included t-tests, Chi-square tests, and generalized estimating equations (GEE).
Main Results:
- At baseline, 13.3-30.0% of RA patients exhibited RC; no patients met criteria for classic cachexia.
- RC prevalence remained stable over the 12-month study period.
- Higher disease activity and use of biologic disease-modifying antirheumatic drugs (bDMARDs) were linked to changes in body composition and physical function.
Conclusions:
- Rheumatoid cachexia is prevalent in RA, whereas classic cachexia is absent.
- Disease activity and bDMARDs significantly influence body composition and physical function in RA.
- Achieving RA remission is crucial for managing body composition and physical function.
More Related Videos
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
The JAK-STAT Signaling Pathway
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease IV: Nursing Management

